Human T-Cell Lymphoma Virus (Htlv, Human T-Cell Lymphocytotrophic Virus)

Human T-Cell Lymphoma Virus (Htlv, Human T-Cell Lymphocytotrophic Virus) is a family of viruses that includes the AIDS virus and the Human T-Cell Lymphoma III virus (or HIV). Other human T-cell lymphoma viruses can cause lymphomas and leukemia in humans.

Htlv viruses are bloodborne and infect human T lymphocytes. They use cellular enzymes to replicate their genetic material. Htlv can remain latent in a cell for years before exerting its pathogenic effects.

The best known viruses of the Htlv family are Htlv-1 and Htlv-2. Htlv-1 can lead to the development of leukemia and T-cell lymphoma. While Htlv-2 does not usually cause disease, there have been cases of its association with hairy leukoplakia.

Htlv is a global health problem and is prevalent in some regions of the world. There is currently no vaccine or treatment, although there is active development in this area. Prevention consists of measures to prevent blood contamination, including through transfusions and the use of injecting drugs.

Human T-cell lymphocytic lymphoma virus (Human T-cell Lymphocytotropic Virus, HTLV) is one of the most dangerous and common viruses in the world. It belongs to a family of viruses that includes the human immunodeficiency virus (HIV). These viruses can infect T lymphocytes and lead to various diseases such as chronic lymphocyte infection, lymphoma and leukemia.

Human T cell lymphoma virus or Human T cell lymphocytotropic virus (HTLV) is a family of viruses belonging to a separate family of lentiviruses (slow viruses or oncoviruses). HTLV affects the blood, gastrointestinal tract, and nervous system. The disease is associated with the formation of malignant tumors.

**Classification** HTLV is a lytic virus and belongs to the retrovirus family. The viruses are subtypes of representatives: HTLV I and HTLV II. After administration intravenously or intramuscularly, a heterogeneous population of these viruses forms a diverse spectrum of immunoglobulins, on which the appearance of the immune response and the development of the disease depend. The form in which the impact is expressed directly depends on the types and subtypes of infection. This leads to the emergence of partial immunity in the infection population - a long-term state of carriage of antigens. Carriers carry the virus in their bodies as their own immune component. The severity of the infection depends on the rate of glycoprotein expression and the state of immunity, but with an average level of immunity, a person can be a carrier without any symptoms. In 2007, J. Pandrolti conducted research into the intra-organizational dynamics of this family of viruses, and also shared assumptions about the possible existence of another part of its representatives in the form of HIV-associated lymphotropes. Subtypes of HTLV The HTLV virus family includes subtypes: 1. HTLV 1; 2. HTLV-2. Of these only